NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
German Cancer Research Center
Groupe Francais De Pneumo-Cancerologie
Shanghai Proton and Heavy Ion Center
Our Lady of the Lake Hospital
German Cancer Research Center
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Australian & New Zealand Children's Haematology/Oncology Group
Anhui Provincial Hospital
Vall d'Hebron Institute of Oncology